T2EVOLVE
Description
Accelerating development and improving access to CAR and TCR-engineered T cell therapy
Accession number
c8c90cbe-c98a-11ed-a11d-ea435b63c148
Project acronym
T2EVOLVE
Project website
Start date
2021-01-01
End date
2025-12-31
Funding
IMI2 - Call 18 (Grant number 945393)
Types